SCHEMBL5183272

SCHEMBL5183272

CCOc1cc2c(cc1OCC)[C@@H](CC)C(C)=NN=C2c1ccccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.53
MEN1 O00255 7/20 0.53
CHRM1 P11229 1/20 0.53
PDE4A P27815 1/20 0.53
PDE4D Q08499 1/20 0.53
PDE3A Q14432 1/20 0.53
POLB P06746 2/20 0.36
GAA P10253 3/20 0.36
MAPT P10636 7/20 0.34
HPGD P15428 5/20 0.34
TSHR P16473 3/20 0.34
ALDH1A1 P00352 6/20 0.34
LMNA P02545 5/20 0.34
HTT P42858 2/20 0.34
ATM Q13315 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALOX15 P16050 3/20 0.34
ALOX12 P18054 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5198392 1.00 KMT2A (0.53) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL5434678 1.00 KMT2A (0.53) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL7412414 0.87 MEN1 (0.60) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL5428125 0.87 MEN1 (0.60) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL5431277 0.87 MEN1 (0.60) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL4586153 0.81 PDE4A (0.71) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL5425871 0.79 MEN1 (0.69) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL5198155 0.79 MEN1 (0.69) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL7408243 0.79 KDM4E (0.37) KMT2AMEN1POLBGAAMAPT
SCHEMBL7441797 0.78 MEN1 (0.67) KMT2AMEN1CHRM1PDE4APDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US claimed
EP-1761507-A1 PHOSPHODIESTERASE-INHIBITING COMPOUNDS OF THE 2,3-BENZODIAZEPINE TYPE Greenpharma (FR) 2007-03-14 EP claimed
WO-2005113517-A1 PHOSPHODIESTERASE-INHIBITING COMPOUNDS OF THE 2,3-BENZODIAZEPINE TYPE GREENPHARMA (FR) 2005-12-01 WO claimed
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161628-A1 Phosphodiesterase inhibitors PDE5A, PDE3A, PDE3B KMT2A 2209/4885MEN1 3432/4885CHRM1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.